QUANTITAT NEUTRON CAPTURE THERAPY AGENT FOR TX PLAN &GD DTPA HOECHST DERIVATIVE
$23,005P41FY2000RRNIH
University Of Illinois At Chicago, Chicago IL
Investigators
Linked publications & trials
Paper 23431144Paper 21606343Paper 17471315Paper 17330156Paper 17330155Paper 17330154Paper 17245440Paper 15010119Paper 14501494Paper 12906239Paper 12670599Paper 12654355Paper 12652532Paper 12541242Paper 12188260Paper 11923642Paper 11923640Paper 11754461Paper 11754438Paper 11700743Paper 11590640Paper 11390265Paper 11378892Paper 11219511Paper 11180424Paper 11118766Paper 10975894
Abstract
Gadolinium isotopes that absorb thermal neutrons may allow gadolinium-based MRI contrast agents to function also as therapeutic agents. Tests of this idea are underway.
View original record on NIH RePORTER →